Nicholas Virca

Nicholas Virca

Chief Executive Officer presso Hedgepath LLC

Patrimonio netto: 610 926 $ in data 31/03/2024

77 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Nicholas Jon Virca is currently the President, Chief Executive Officer & Director at Hedgepath LLC since 2012.
Previously, he held the position of President & Chief Executive Officer at Mast Therapeutics, Inc. from 1997 to 2004.
He also served as the President & Chief Executive Officer at Inhibitor Therapeutics, Inc. from 2014 to 2022.
Additionally, he worked as a Director at Panoptix Events from 2007 to 2017 and as a Director at Diametrix Detectors, Inc. from 1991 to 1997.
Furthermore, he held the role of Vice President-Global Biotechnology at Pall Corp.
and Cytiva US LLC from 2005 to 2008.
Lastly, he served as the Chief Operating Officer at LamdaGen Corp.
from 2008 to 2012.
Mr. Virca obtained his undergraduate degree from Youngstown State University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
29/03/2024 8 727 519 ( 5.07% ) 610 926 $ 31/03/2024

Posizioni attive di Nicholas Virca

SocietàPosizioneInizio
Hedgepath LLC Chief Executive Officer 01/04/2012
Tutte le posizioni attive di Nicholas Virca

Precedenti posizioni note di Nicholas Virca

SocietàPosizioneFine
INHIBITOR THERAPEUTICS, INC. Chief Executive Officer 13/12/2022
Director/Board Member 01/01/2017
Chief Operating Officer 01/04/2012
PALL CORPORATION Corporate Officer/Principal 01/01/2008
Corporate Officer/Principal 01/01/2008
Vedi nel dettaglio l'esperienza di Nicholas Virca

Formazione di Nicholas Virca

Youngstown State University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Nicholas Virca

Relazioni

37

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private8

Health Technology

Health Technology

Hedgepath LLC

Health Technology

Commercial Services

Inhibitor Therapeutics, Inc.

Commercial Services

Diametrix Detectors, Inc.

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Nicholas Virca